Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OTLK Outlook Therapeutics, Inc.

盘后交易 04-22 18:33:29 EDT

1.50

+0.03

+2.04%

盘后1.50

+0.000.00%

17:21 EDT

最高1.54	最低1.43	成交量29.59万
今开1.47	昨收1.47	日振幅7.14%
总市值4,893万	流通市值3,111万	总股本3,262万
成交额44.08万	换手率1.43%	流通股本2,074万
市净率-0.97	ROE-3.65%	每股收益-2.19
52周最高9.29	52周最低0.8700	市盈率-0.68
股息0.00	股息收益率0.00	ROA-268.11%

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OTLK","market":"US","secType":"STK","nameCN":"Outlook Therapeutics, Inc.","latestPrice":1.5,"timestamp":1745352000000,"preClose":1.47,"halted":0,"volume":295924,"hourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.5,"latestTime":"17:21 EDT","volume":1010,"amount":1515,"timestamp":1745356903294},"delay":0,"floatShares":20740032,"shares":32620177,"eps":-2.192125,"marketStatus":"盘后交易","change":0.03,"latestTime":"04-22 18:33:29 EDT","open":1.47,"high":1.535,"low":1.43,"amount":440796.93814120005,"amplitude":0.071429,"askPrice":1.62,"askSize":100,"bidPrice":1.32,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.192125,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.47,"postHourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.5,"latestTime":"17:21 EDT","volume":1010,"amount":1515,"timestamp":1745356903294},"volumeRatio":1.040929,"impliedVol":0.0015,"impliedVolPercentile":0.016},"requestUrl":"/m/hq/s/OTLK","defaultTab":"news","newsList":[{"id":"2528725246","title":"Outlook Therapeutics, Inc.盘中异动 大幅拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528725246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528725246?lang=zh_cn&edition=full","pubTime":"2025-04-18 00:22","pubTimestamp":1744906938,"startTime":"0","endTime":"0","summary":"北京时间2025年04月18日00时22分，Outlook Therapeutics, Inc.股票出现异动，股价大幅拉升5.10%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.87%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418002218a45cc796&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418002218a45cc796&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","OTLK"],"gpt_icon":0},{"id":"2527519873","title":"Outlook Therapeutics, Inc.盘中异动 股价大涨5.07%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527519873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527519873?lang=zh_cn&edition=full","pubTime":"2025-04-14 22:24","pubTimestamp":1744640650,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时24分，Outlook Therapeutics, Inc.股票出现异动，股价大幅上涨5.07%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Theratechnologies Inc.、Third Harmonic Bio, Inc.、Metsera, Inc.涨幅较大，Artelo Biosciences, Inc.、Aditxt, Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为572.07%、311.23%、148.53%，振幅较大的相关个股有Artelo Biosciences, Inc.、Theratechnologies Inc.、Fate Therapeutics, Inc.，振幅分别为48.67%、29.90%、24.99%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414222410a458994b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414222410a458994b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2518042662","title":"Outlook Therapeutics, Inc.盘中异动 下午盘股价大跌5.34%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518042662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518042662?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:56","pubTimestamp":1741633004,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时56分，Outlook Therapeutics, Inc.股票出现异动，股价急速下跌5.34%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6148.90%、3854.04%、1014.79%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、59.34%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311025644a26a9d94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311025644a26a9d94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","OTLK"],"gpt_icon":0},{"id":"2517698565","title":"Outlook Therapeutics, Inc.盘中异动 下午盘股价大涨5.28%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517698565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517698565?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:19","pubTimestamp":1741119563,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时19分，Outlook Therapeutics, Inc.股票出现异动，股价急速上涨5.28%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041923a25f65a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305041923a25f65a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","OTLK"],"gpt_icon":0},{"id":"2516688296","title":"Outlook Therapeutics, Inc.盘中异动 下午盘股价大跌5.00%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516688296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516688296?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:02","pubTimestamp":1741032163,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时02分，Outlook Therapeutics, Inc.股票出现异动，股价大幅跳水5.00%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4576.31%、211.77%、182.41%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040243abe68edc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304040243abe68edc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2514566375","title":"Outlook Therapeutics, Inc.盘中异动 早盘快速拉升5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514566375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514566375?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:53","pubTimestamp":1740754380,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时53分，Outlook Therapeutics, Inc.股票出现异动，股价急速上涨5.80%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225300abe0f06f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225300abe0f06f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","OTLK"],"gpt_icon":0},{"id":"2514045867","title":"Outlook Therapeutics, Inc.盘中异动 下午盘股价大跌5.23%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514045867","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514045867?lang=zh_cn&edition=full","pubTime":"2025-02-26 03:28","pubTimestamp":1740511706,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日03时28分，Outlook Therapeutics, Inc.股票出现波动，股价急速跳水5.23%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226032826abdcc28f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226032826abdcc28f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2513214988","title":"Outlook Therapeutics, Inc.盘中异动 股价大跌5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513214988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513214988?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:07","pubTimestamp":1740168426,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时07分，Outlook Therapeutics, Inc.股票出现异动，股价急速下挫5.43%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Moolec Science Sa C/Wts 涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为316.92%、251.10%、138.24%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222040707a24ef57e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222040707a24ef57e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","OTLK"],"gpt_icon":0},{"id":"2512166707","title":"Outlook Therapeutics, Inc.盘中异动 股价大跌5.35%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166707?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:01","pubTimestamp":1739890874,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时01分，Outlook Therapeutics, Inc.股票出现异动，股价急速下挫5.35%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230114abd3b5ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218230114abd3b5ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","OTLK"],"gpt_icon":0},{"id":"2511257095","title":"Outlook Therapeutics, Inc.盘中异动 临近收盘快速上涨5.17%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511257095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511257095?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:50","pubTimestamp":1739479816,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时50分，Outlook Therapeutics, Inc.股票出现波动，股价急速拉升5.17%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Moleculin Biotech, Inc.、Dominari Holdings Inc.、Edesa Biotech, Inc.涨幅较大，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3288.28%、2317.46%、1269.38%，振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为733.31%、95.15%、92.30%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214045016988475bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214045016988475bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","OTLK"],"gpt_icon":0},{"id":"2510332620","title":"Outlook Therapeutics, Inc.盘中异动 股价大跌5.33%报1.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510332620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510332620?lang=zh_cn&edition=full","pubTime":"2025-02-12 01:05","pubTimestamp":1739293558,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日01时05分，Outlook Therapeutics, Inc.股票出现异动，股价大幅下跌5.33%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.74%。其相关个股中，Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为3014.30%、1344.27%、439.69%，振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.，振幅分别为143.33%、59.46%、58.60%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120105589881d747&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120105589881d747&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0},{"id":"2510894173","title":"Outlook Therapeutics, Inc.盘中异动 快速下挫5.26%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510894173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510894173?lang=zh_cn&edition=full","pubTime":"2025-02-11 04:04","pubTimestamp":1739217899,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日04时04分，Outlook Therapeutics, Inc.股票出现波动，股价急速下跌5.26%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.95%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110404599880b79d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502110404599880b79d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ","BK4139"],"gpt_icon":0},{"id":"2509786716","title":"Outlook Therapeutics, Inc.盘中异动 下午盘大幅下挫5.08%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509786716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509786716?lang=zh_cn&edition=full","pubTime":"2025-02-07 04:28","pubTimestamp":1738873734,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日04时28分，Outlook Therapeutics, Inc.股票出现异动，股价急速下挫5.08%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.70%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207042854987cc11b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207042854987cc11b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ","BK4139"],"gpt_icon":0},{"id":"2509528298","title":"Outlook Therapeutics, Inc.盘中异动 急速下跌6.85%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509528298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509528298?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:31","pubTimestamp":1738765902,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时31分，Outlook Therapeutics, Inc.股票出现异动，股价大幅跳水6.85%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals, Inc.、Oragenics Inc.较为活跃，换手率分别为2635.51%、595.53%、583.64%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Eyepoint Pharmaceuticals, Inc.、Oragenics Inc.，振幅分别为16.82%、11.68%、9.75%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223142abc37d7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223142abc37d7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","OTLK"],"gpt_icon":0},{"id":"2508246149","title":"Outlook Therapeutics, Inc.盘中异动 大幅下挫5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508246149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508246149?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:32","pubTimestamp":1738593145,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时32分，Outlook Therapeutics, Inc.股票出现波动，股价急速下挫5.81%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为323.74%、236.31%、126.79%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Briacell Therapeutics Corp.，振幅分别为35.77%、33.33%、13.55%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032232259616fb7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032232259616fb7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ","BK4139"],"gpt_icon":0},{"id":"2507969682","title":"Outlook Therapeutics, Inc.盘中异动 快速拉升7.43%报2.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507969682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507969682?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:46","pubTimestamp":1738334803,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时46分，Outlook Therapeutics, Inc.股票出现波动，股价快速拉升7.43%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.26%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131224643abbe3e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131224643abbe3e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","LENZ","BK4139"],"gpt_icon":0},{"id":"2506475301","title":"Outlook Therapeutics, Inc.盘中异动 早盘急速下跌5.03%报1.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506475301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506475301?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:50","pubTimestamp":1737993008,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时50分，Outlook Therapeutics, Inc.股票出现异动，股价急速下挫5.03%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Dogwood Therapeutics, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Evaxion Biotech As较为活跃，换手率分别为1916.85%、362.03%、213.54%，振幅较大的相关个股有Onconetix, Inc.、Dogwood Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为85.35%、75.00%、65.16%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272350089874bd36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501272350089874bd36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","OTLK","BK4139"],"gpt_icon":0},{"id":"2505804028","title":"Outlook Therapeutics, Inc.盘中异动 股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505804028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505804028?lang=zh_cn&edition=full","pubTime":"2025-01-24 03:28","pubTimestamp":1737660535,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日03时28分，Outlook Therapeutics, Inc.股票出现异动，股价急速下挫5.26%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6846.11%、5263.18%、702.52%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Transcode Therapeutics, Inc.，振幅分别为948.57%、145.99%、85.67%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124032856abb634b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124032856abb634b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OTLK","LENZ"],"gpt_icon":0},{"id":"2505277267","title":"Outlook Therapeutics, Inc.盘中异动 早盘股价大跌5.01%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505277267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505277267?lang=zh_cn&edition=full","pubTime":"2025-01-22 23:51","pubTimestamp":1737561114,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日23时51分，Outlook Therapeutics, Inc.股票出现异动，股价大幅跳水5.01%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122235154a22bc392&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122235154a22bc392&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","OTLK"],"gpt_icon":0},{"id":"2504162387","title":"Outlook Therapeutics, Inc.盘中异动 大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504162387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504162387?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:49","pubTimestamp":1737125361,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时49分，Outlook Therapeutics, Inc.股票出现波动，股价快速下跌5.02%。Outlook Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Outlook Therapeutics, Inc.公司简介：Outlook Therapeutics Inc 是一家临床阶段生物制药公司，专注于开发和商业化 ONS-5010，这是一种用于各种眼科适应症的单克隆抗体 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117224921a225bfeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117224921a225bfeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OTLK","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.outlooktherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0576},{"period":"1month","weight":-0.0265},{"period":"3month","weight":-0.3595},{"period":"6month","weight":-0.7211},{"period":"1year","weight":-0.8201},{"period":"ytd","weight":-0.2222}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Outlook Therapeutics, Inc.于2010年1月5日在新泽西州注册成立。该公司是一家生物制药公司，在欧盟或欧盟、英国或英国率先获得ONS-5010/LYTENAVA（贝伐珠单抗-gamma）眼科制剂上市许可，用于治疗湿性年龄相关性黄斑变性，或湿性AMD。该公司正在开发ONS-5010/LYTENAVA，作为玻璃体内注射液给药，用于治疗湿性AMD和视网膜疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.117155},{"month":2,"riseRate":0.444444,"avgChangeRate":0.160578},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.049534},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.111527},{"month":5,"riseRate":0.625,"avgChangeRate":0.151955},{"month":6,"riseRate":0.375,"avgChangeRate":-0.036511},{"month":7,"riseRate":0.555556,"avgChangeRate":0.021804},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.135567},{"month":9,"riseRate":0.444444,"avgChangeRate":0.026948},{"month":10,"riseRate":0.444444,"avgChangeRate":0.175694},{"month":11,"riseRate":0.111111,"avgChangeRate":-0.160695},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.106019}],"exchange":"NASDAQ","name":"Outlook Therapeutics, Inc.","nameEN":"Outlook Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Outlook Therapeutics, Inc.,OTLK,Outlook Therapeutics, Inc.股票,Outlook Therapeutics, Inc.股票老虎,Outlook Therapeutics, Inc.股票老虎国际,Outlook Therapeutics, Inc.行情,Outlook Therapeutics, Inc.股票行情,Outlook Therapeutics, Inc.股价,Outlook Therapeutics, Inc.股市,Outlook Therapeutics, Inc.股票价格,Outlook Therapeutics, Inc.股票交易,Outlook Therapeutics, Inc.股票购买,Outlook Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Outlook Therapeutics, Inc.(OTLK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Outlook Therapeutics, Inc.(OTLK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}